AKBA Earnings

Quarterly EPS
$-0.10
Q3 2024
$-0.10
Q4 2024
$0.03
Q1 2025
$0.00
Q2 2025
$0.00
Q3 2025
$-0.05
Q4 2025
$-0.03
Q1 2026
$-0.03
Q2 2026
Latest Revenue49.1M
Latest Net Income-8908000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.0349.1M-8908000-21.4%
Q1 2026-$0.0353.5M-9054000-6.6%-200.0%
Q4 2025-$0.0557.6M-12244000+23.9%+50.0%
Q3 2025$0.0058.8M540.0K+57.0%+100.0%
Q2 2025$0.0062.5M247.0K+43.1%+100.0%
Q1 2025$0.0357.3M6.1M+75.8%+133.3%
Q4 2024-$0.1046.5M-22804000-17.3%
Q3 2024-$0.1037.4M-20039000-11.0%-25.0%
Q2 2024-$0.0443.6M-8582000
Q1 2024-$0.0932.6M-17985000
Q4 2023$0.0056.2M614.0K
Q3 2023-$0.0842.0M-14489000
Akebia Therapeutics (AKBA) — Earnings